UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

EPS6.8 Development of a virtual ward model of care for adults with cystic fibrosis (CF) requiring home intravenous (IV) antibiotics

Journal of cystic fibrosis, 2017-06, Vol.16, p.S51-S52

2017

Volltextzugriff (PDF)

ePS05.2 Autologous blood patch pleurodesis for persistent air leak in adults with cystic fibrosis

Journal of cystic fibrosis, 2016-06, Vol.15, p.S46-S46

2016

Volltextzugriff (PDF)

334 Dietary modification for treatment of glucose abnormalities in adults with cystic fibrosis

Journal of cystic fibrosis, 2017-06, Vol.16, p.S148-S148

2017

Volltextzugriff (PDF)

328 Going the distance – patient opinion on an adult CF centre dietetic and diabetes home visit service

Journal of cystic fibrosis, 2017-06, Vol.16, p.S146-S146

2017

Volltextzugriff (PDF)

285 The use of dipeptidyl peptidase-4 inhibitors (DPP-4) in CF-related diabetes (CFRD)

Journal of cystic fibrosis, 2017-06, Vol.16, p.S134-S135

2017

Volltextzugriff (PDF)

137 Transcutaneous ear probe oxygenation readings are significantly higher than finger probe oxygenation readings in CF adults

Journal of cystic fibrosis, 2016-06, Vol.15, p.S86-S86

2016

Volltextzugriff (PDF)

287 Seasonal variation in vitamin D status in an adult CF clinic population

Journal of cystic fibrosis, 2013-06, Vol.12, p.S121-S121

2013

Volltextzugriff (PDF)

255 Cystic fibrosis patients acting as carers for their older relatives – the ‘cared for’ becoming the carer

Journal of cystic fibrosis, 2014-06, Vol.13, p.S113-S113

2014

Volltextzugriff (PDF)

39 ‘Real world’ tolerability, ease of use, patient satisfaction and reported adherence in CF adults commencing Colobreathe

Journal of cystic fibrosis, 2014-06, Vol.13, p.S56-S56

2014

Volltextzugriff (PDF)

220 Safety, tolerability and patient preference of intravenous colistimethate sodium delivered by bolus compared to infusion in adults with cystic fibrosis

Journal of cystic fibrosis, 2014-06, Vol.13, p.S103-S103

2014

Volltextzugriff (PDF)

67 Clinical outcomes and patient satisfaction following initiation of the TOBI Podhaler in CF adults

Journal of cystic fibrosis, 2013-06, Vol.12, p.S65-S65

2013

Volltextzugriff (PDF)

Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis

The Journal of hospital infection, 2012-06, Vol.81 (2), p.104-108

2012

Volltextzugriff (PDF)

216 A UK survey on the assessment and management of CF-associated liver disease

Journal of cystic fibrosis, 2012-06, Vol.11, p.S112-S112

2012

Volltextzugriff (PDF)

P325 An audit of an adult CF centre bone health screening programme post COVID-19

Journal of cystic fibrosis, 2024-06, Vol.23, p.S168-S168

2024

Volltextzugriff (PDF)

260 A prospective cohort study examining the prevalence of emotional and behavioural difficulties in children of patients with cystic fibrosis (CF)

Journal of cystic fibrosis, 2014-06, Vol.13, p.S114-S114

2014

Volltextzugriff (PDF)

68 Comparison of pharmacy prescription refill frequency in CF adults before and after switching from tobramycin inhalation solution (TIS) to TOBI Podhaler – ‘Real world’ evidence of improved adherence

Journal of cystic fibrosis, 2013-06, Vol.12, p.S65-S65

2013

Volltextzugriff (PDF)

138 Urinary inflammatory markers in the assessment of clinical status in adults with CF

Journal of cystic fibrosis, 2012-06, Vol.11, p.S92-S92

2012

Volltextzugriff (PDF)

148 Use of whole-genome sequencing to identify transmission of Pseudomonas aeruginosa between cystic fibrosis patients

Journal of cystic fibrosis, 2014-06, Vol.13, p.S84-S84

2014

Volltextzugriff (PDF)

P412 A patient-led review of outpatient services following the COVID-19 pandemic and widespread introduction of highly-effective modulator treatments and remote monitoring devices

Journal of cystic fibrosis, 2023-06, Vol.22, p.S190-S190

2023

Volltextzugriff (PDF)

P161 Body mass index change in adult patients with cystic fibrosis following the introduction of triple CFTR therapy elexacaftor/tezacaftor/ivacaftor: a regional adult cystic fibrosis centre experience

Journal of cystic fibrosis, 2022-06, Vol.21, p.S110

2022

Volltextzugriff (PDF)

End of life care in cystic fibrosis – are we offering a good service?

Journal of cystic fibrosis, 2010, Vol.9, p.S66-S66

2010

Volltextzugriff (PDF)

Clinical status of adolescent CF patients before and after transition from paediatric to adult services

Journal of cystic fibrosis, 2010, Vol.9, p.S117-S117

2010

Volltextzugriff (PDF)

P176 The benefits of changing to a cystic fibrosis-specific combined fatsoluble vitamin supplement: vitamin status, tablet burden and adherence

Journal of cystic fibrosis, 2021, Vol.20, p.S92

2021

Volltextzugriff (PDF)

P192 The introduction of a quality improvement focus group in a large UK adult cystic fibrosis centre

Journal of cystic fibrosis, 2021, Vol.20, p.S97-S98

2021

Volltextzugriff (PDF)

P333 Refresh: patient experience of an online healthy eating webinar designed specifically for adults with cystic fibrosis on CFTR modulators

Journal of cystic fibrosis, 2023-06, Vol.22, p.S166-S167

2023

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(71)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Pulmonary/respiratory
(21)
Science & Technology
(13)
Life Sciences & Biomedicine
(11)
Humans
(8)
Biological And Medical Sciences
(6)
Medical Sciences
(5)
Adult
(4)
Animals
(4)
Cystic Fibrosis
(4)
Female
(3)
General Aspects
(3)
Male
(3)
Administration, Oral
(2)
Adolescent
(2)
Biochemistry & Molecular Biology
(2)
Bronchiolitis
(2)
Bronchiolitis - Drug Therapy
(2)
Bronchodilator Agents - Administration & Dosage
(2)
Child
(2)
Chronic Obstructive Pulmonary Disease, Asthma
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

EPS6.8 Development of a virtual ward model of care for adults with cystic fibrosis (CF) requiring home intravenous (IV) antibiotics

ePS05.2 Autologous blood patch pleurodesis for persistent air leak in adults with cystic fibrosis

334 Dietary modification for treatment of glucose abnormalities in adults with cystic fibrosis

328 Going the distance – patient opinion on an adult CF centre dietetic and diabetes home visit service

285 The use of dipeptidyl peptidase-4 inhibitors (DPP-4) in CF-related diabetes (CFRD)

137 Transcutaneous ear probe oxygenation readings are significantly higher than finger probe oxygenation readings in CF adults

287 Seasonal variation in vitamin D status in an adult CF clinic population

255 Cystic fibrosis patients acting as carers for their older relatives – the ‘cared for’ becoming the carer

39 ‘Real world’ tolerability, ease of use, patient satisfaction and reported adherence in CF adults commencing Colobreathe

220 Safety, tolerability and patient preference of intravenous colistimethate sodium delivered by bolus compared to infusion in adults with cystic fibrosis

67 Clinical outcomes and patient satisfaction following initiation of the TOBI Podhaler in CF adults

Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis

216 A UK survey on the assessment and management of CF-associated liver disease

P325 An audit of an adult CF centre bone health screening programme post COVID-19

260 A prospective cohort study examining the prevalence of emotional and behavioural difficulties in children of patients with cystic fibrosis (CF)

68 Comparison of pharmacy prescription refill frequency in CF adults before and after switching from tobramycin inhalation solution (TIS) to TOBI Podhaler – ‘Real world’ evidence of improved adherence

138 Urinary inflammatory markers in the assessment of clinical status in adults with CF

148 Use of whole-genome sequencing to identify transmission of Pseudomonas aeruginosa between cystic fibrosis patients

P412 A patient-led review of outpatient services following the COVID-19 pandemic and widespread introduction of highly-effective modulator treatments and remote monitoring devices

P161 Body mass index change in adult patients with cystic fibrosis following the introduction of triple CFTR therapy elexacaftor/tezacaftor/ivacaftor: a regional adult cystic fibrosis centre experience

End of life care in cystic fibrosis – are we offering a good service?

Clinical status of adolescent CF patients before and after transition from paediatric to adult services

P176 The benefits of changing to a cystic fibrosis-specific combined fatsoluble vitamin supplement: vitamin status, tablet burden and adherence

P192 The introduction of a quality improvement focus group in a large UK adult cystic fibrosis centre

P333 Refresh: patient experience of an online healthy eating webinar designed specifically for adults with cystic fibrosis on CFTR modulators

Aktive Filter

Suchergebnisse filtern